The India intravenous solutions market is expected to grow at a CAGR of 5.80% between 2023 and 2028. Major market drivers include fast response rate, higher efficacy, and versatile applications.
Intravenous solutions, also known as intravenous fluids, are formulated liquids that are given intravenously by injecting into the person’s vein to maintain or restore normal fluid balance and nutrient levels. The intravenous solutions contain various nutrients. The three main types of intravenous solutions are hypotonic, isotonic, and hypertonic. Hypotonic has lower concentration of sugar, fluids, and salts in comparison to blood whereas hypertonic solutions have higher concentrations of these components as compared to blood. Isotonic has equal concentration of fluid, salts, and sugar in comparison to blood.
Based on type, the India intravenous solutions market can be bifurcated into partial parenteral nutrition and total parenteral nutrition. By nutrients, the market is divided into carbohydrates, salts and electrolytes, minerals, vitamins, minerals, and amino acids, among others. By region, the market is segmented into North India, West and Central India, South India, and East India.
The comprehensive EMR report provides an in-depth assessment of the market based on the Porter's five forces model along with giving a SWOT analysis. The report gives a detailed analysis of the following key players in the India intravenous solutions market covering their competitive landscape and latest developments like mergers, acquisitions, investments, and expansion plans.
Total parenteral nutrition segment is expected to account for a larger share in the India intravenous solutions market as it is widely used by healthcare providers due to the safety it provides in administration. Providing complete nutritional requirements intravenously, total parenteral nutrition has higher concentration of nutrients and is typically administered through larger veins. As the IV is connected into larger veins, there is lower risk of infection.
Partial parenteral nutrition provides a part of daily nutritional requirements and is used as a supplement for patients that have other nutrition sources. Due to its versatile applications for various conditions the demand is expected to rise. However, partial parenteral nutrition is typically administered via catheter insertion into smaller veins, increasing the risk of infection.
Salts and electrolytes are leading segment of the India intravenous solutions market due to their role in combating dehydration and increasing cases of malnutrition. Inadequate nutrition can cause deficiency of minerals, fatigue, reduced immunity, and weak bones in the individual. Salts and electrolytes are used for the regulation of muscle and nerve function, body hydration and to rebuild any damaged tissues.
Amino acids in combination with dextrose, vitamins and other elements are given in the form of dietary supplements to boost protein and calorie intake. They are often used post-surgery or after certain illnesses to provide missing nutrients and meet the metabolic protein requirements of patients.
Eurolife Healthcare Pvt. Ltd. is a pharmaceutical company that manufactures and distributes intravenous infusions, injections, capsules, ointments, creams, ophthalmic products, formulations, tablets, and nebules to its customers globally. It has its headquarter in Mumbai in Maharashtra and was founded in 2001. With their world class quality and competitive rate, they have successfully been accepted in every place they have marketed.
Nymak Pharma Ltd. was established in 1998 and is headquartered in Gandhidham, Gujarat. It is a public company involved in the machinery and equipment manufacturing sector. It manufactures and exports quality products including sterile water for injections, IV fluids, cough syrup, surgical sutures, syringes with needles, ringer lactate, ORS water, and paracetamol IV, among others.
Amanta Healthcare Limited was founded in 1988 and is based in Ahmedabad, Gujarat. It is a pharmaceutical manufacturing company that provides a range of products for domestic markets and international markets. Some of the products provided include electrolyte replacements, diuretics, anti-fungal solutions, common solutions, anti-biotic solutions, and anti-infective solutions, among others.
Other market players include Claris Lifesciences Ltd., Schwitz Biotech, Parenteral Drugs (India) Limited, Soxa Formulations & Research (Pvt.) Ltd, and Kritikos Care, among others.
|Scope of the Report||
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|Breakup by Type||
|Breakup by Nutrient||
|Breakup by Region||
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
2 Report Coverage – Key Segmentation and Scope
3 Report Description
3.1 Market Definition and Outlook
3.2 Properties and Applications
3.3 Market Analysis
3.4 Key Players
4 Key Assumptions
5 Executive Summary
5.2 Key Drivers
5.3 Key Developments
5.4 Competitive Structure
5.5 Key Industrial Trends
6 Market Snapshot
7 Opportunities and Challenges in the Market
8 India Intravenous Solutions Market Analysis
8.1 Key Industry Highlights
8.2 India Intravenous Solutions Historical Market (2018-2022)
8.3 India Intravenous Solutions Market Forecast (2023-2028)
8.4 India Intravenous Solutions Market by Type
8.4.1 Partial Parenteral Nutrition
126.96.36.199 Market Share
188.8.131.52 Historical Trend (2018-2022)
184.108.40.206 Forecast Trend (2023-2028)
8.4.2 Total Parenteral Nutrition
220.127.116.11 Market Share
18.104.22.168 Historical Trend (2018-2022)
22.214.171.124 Forecast Trend (2023-2028)
8.5 India Intravenous Solutions Market by Nutrient
126.96.36.199 Market Share
188.8.131.52 Historical Trend (2018-2022)
184.108.40.206 Forecast Trend (2023-2028)
8.5.2 Salts and Electrolytes
220.127.116.11 Market Share
18.104.22.168 Historical Trend (2018-2022)
22.214.171.124 Forecast Trend (2023-2028)
126.96.36.199 Market Share
188.8.131.52 Historical Trend (2018-2022)
184.108.40.206 Forecast Trend (2023-2028)
220.127.116.11 Market Share
18.104.22.168 Historical Trend (2018-2022)
22.214.171.124 Forecast Trend (2023-2028)
8.5.5 Amino Acids
126.96.36.199 Market Share
188.8.131.52 Historical Trend (2018-2022)
184.108.40.206 Forecast Trend (2023-2028)
8.6 India Intravenous Solutions Market by Region
8.6.1 Market Share
220.127.116.11 North India
18.104.22.168 West and Central India
22.214.171.124 South India
126.96.36.199 East India
9 Regional Analysis
9.1 North India
9.1.1 Historical Trend (2018-2022)
9.1.2 Forecast Trend (2023-2028)
9.2 West and Central India
9.2.1 Historical Trend (2018-2022)
9.2.2 Forecast Trend (2023-2028)
9.3 South India
9.3.1 Historical Trend (2018-2022)
9.3.2 Forecast Trend (2023-2028)
9.4 East India
9.4.1 Historical Trend (2018-2022)
9.4.2 Forecast Trend (2023-2028)
10 Market Dynamics
10.1 SWOT Analysis
10.2 Porter’s Five Forces Analysis
10.2.1 Supplier’s Power
10.2.2 Buyer’s Power
10.2.3 Threat of New Entrants
10.2.4 Degree of Rivalry
10.2.5 Threat of Substitutes
10.3 Key Indicators for Demand
10.4 Key Indicators for Price
11 Competitive Landscape
11.1 Market Structure
11.2 Company Profiles
11.2.1 Eurolife Healthcare Pvt. Ltd.
188.8.131.52 Company Overview
184.108.40.206 Product Portfolio
220.127.116.11 Demographic Reach and Achievements
11.2.2 Claris Lifesciences Ltd.
18.104.22.168 Company Overview
22.214.171.124 Product Portfolio
126.96.36.199 Demographic Reach and Achievements
11.2.3 Nymak Pharma Ltd
188.8.131.52 Company Overview
184.108.40.206 Product Portfolio
220.127.116.11 Demographic Reach and Achievements
11.2.4 Amanta Healthcare Limited
18.104.22.168 Company Overview
22.214.171.124 Product Portfolio
126.96.36.199 Demographic Reach and Achievements
11.2.5 Schwitz Biotech
188.8.131.52 Company Overview
184.108.40.206 Product Portfolio
220.127.116.11 Demographic Reach and Achievements
11.2.6 Parenteral Drugs (India) Limited
18.104.22.168 Company Overview
22.214.171.124 Product Portfolio
126.96.36.199 Demographic Reach and Achievements
11.2.7 Soxa Formulations & Research (Pvt.) Ltd,
188.8.131.52 Company Overview
184.108.40.206 Product Portfolio
220.127.116.11 Demographic Reach and Achievements
11.2.8 Kritikos Care
18.104.22.168 Company Overview
22.214.171.124 Product Portfolio
126.96.36.199 Demographic Reach and Achievements
12 Key Trends and Developments in the Market
List of Figures and Tables
1. India Intravenous Solutions Market: Key Industry Highlights, 2018 and 2028
2. India Intravenous Solutions Historical Market: Breakup by Types (USD Million), 2018-2022
3. India Intravenous Solutions Market Forecast: Breakup by Types (USD Million), 2023-2028
4. India Intravenous Solutions Historical Market: Breakup by Nutrients (USD Million), 2018-2022
5. India Intravenous Solutions Market Forecast: Breakup by Nutrients (USD Million), 2023-2028
6. India Intravenous Solutions Historical Market: Breakup by Region (USD Million), 2018-2022
7. India Intravenous Solutions Market Forecast: Breakup by Region (USD Million), 2023-2028
8. India Intravenous Solutions Market Structure
The intravenous solutions market in India is expected to grow at a CAGR of 5.80% between 2023 and 2028.
Major market drivers include fast response rate of patients to intravenous solutions, higher efficacy, and wider applications.
The key trends of the market are prevalence of malnutrition, increasing number of cancer cases, and expansion of healthcare infrastructure in the country.
Key market players include Eurolife Healthcare Pvt. Ltd., Claris Lifesciences Ltd., Nymak Pharma Ltd., Amanta Healthcare Limited, Schwitz Biotech, Parenteral Drugs (India) Limited, Soxa Formulations & Research (Pvt.) Ltd, and Kritikos Care, among others.
Intravenous solutions are formulated liquids that are given intravenously by injecting into the person’s vein to maintain or restore normal fluid and nutrient balance.
The three main types of intravenous solutions are hypotonic, isotonic, and hypertonic.
The India intravenous solutions market is segmented based on type, nutrient, and region.
Hypotonic solutions have lower concentrations of sugar, fluid, and salt in comparison to blood unlike hypertonic solution which has higher concentration of the components than blood.
The primary types of intravenous solutions are partial parenteral nutrition and total parenteral nutrition.
Single User License
Five User License
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.